Mucopolysaccharidoses: future therapies and perspectives

Susanne Gerit Kircher from the Medical University of Vienna and the Austrian MPS Society discusses how Mucopolysaccharidoses diseases are actually curable. Mucopolysaccharidoses (MPS) are a group of very rare disorders, also known as orphan diseases. They belong to the group...

Zellweger UK: A glimmer of hope

Peroxisome biogenesis disorders in the Zellweger spectrum (PBD-ZSD) are a heterogeneous group of genetic disorders caused by mutations in PEX genes responsible for normal peroxisome assembly and functions. Peroxisomes are membrane-bound organelles found in nearly all eukaryotic cells. They contain...

Ordered nanocylinder arrays in solar cells

Ultrathin layers and ordered nanocylinder arrays in solar cells made from alternative materials. With his ERC Grant 'Solacylin', Professor Julien Bachmann and his team at the University of Erlangen control interfaces in photovoltaic devices for optimised performance on the basis...

Nanotechnologies – almost there – what’s next?

The Joint Research Centre’s Dr Elke Anklam spoke to SEQ about how the European Commission is supporting nanotechnologies. In June, Innovation News Network travelled to Bucharest, Romania, to attend the 2019 instalment of the EuroNanoForum, a conference that brought together...

Dr Ann Moen on the global influenza strategy

Dr Ann Moen, Chief of the WHO’s Influenza Preparedness & Response Unit (IPR), explains the importance of their latest strategy: the Global Influenza Strategy 2019-2030. Influenza is a serious global health threat that impacts all countries: every year, there are...

Dietary fibre: Relating functionality to molecular structure

Dietary fibres confer numerous benefits as part of a healthy diet, but these are specific to which fibres are consumed. Dietary fibres are indigestible carbohydrates that confer many potential health benefits, including risk reductions for several chronic diseases, but both...

Disease diagnosis and environment-specific tissue engineering

We speak to G.E.R.N Director, Prof B Rolauffs, about tackling the problems with the current translation of tissue engineering towards clinical use. G.E.R.N. is the Research Center for Tissue Replacement, Regeneration & Neogenesis of the Freiburg University Medical Center. The...

Preclinical drug development for childhood cancers

Research at Greehey Children’s Cancer Research Institute (Greehey CCRI) has been at the forefront of improving relevant preclinical models for developing new therapeutics. Cancer in children remains the major cause of disease-related death in the U.S. Although childhood cancers are...

The E-MRS: supporting materials science & engineering in Europe

Most of the problems facing the world, such as energy supply and health, will be solved only by breakthroughs in materials science: meet the European Materials Research Society. The European materials research and engineering community is composed in a quite...

Chronic hepatitis B remains a global health problem

Re-designing the hepatitis B vaccine: helping WHO achieve one of the 2030 elimination targets as Chronic hepatitis B (CHB) remains a global health problem. According to WHO, as the epidemics of HIV, malaria, and tuberculosis retroceded, viral hepatitis became more...

Featured Topics


Research & Discovery